This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Top analysts changed outlook on top names. See analyst ratings page for all changes.
Read original at benzingaStocks · News reference
Sinda Q2 EPS $(0.13) Misses $(0.09) Estimate
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 14, 2026, 4:12 PM
- Checked
- Aug 14, 2026, 4:12 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Canaccord Genuity Initiates Coverage On Sinda with Speculative Buy Rating, Announces Price Target of $19
Canaccord Genuity analyst Peter Bell initiates coverage on Sinda (NYSE:SIND) with a Speculative Buy rating and announces Price Target of $19.
Read original at benzingaBMO Capital Maintains Outperform on Sinda, Raises Price Target to $19
BMO Capital analyst Kevin O'Halloran maintains Sinda (NYSE:SIND) with a Outperform and raises the price target from $16 to $19.
Read original at benzinga